WO1993009808A1 - METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R - Google Patents
METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R Download PDFInfo
- Publication number
- WO1993009808A1 WO1993009808A1 PCT/US1992/008977 US9208977W WO9309808A1 WO 1993009808 A1 WO1993009808 A1 WO 1993009808A1 US 9208977 W US9208977 W US 9208977W WO 9309808 A1 WO9309808 A1 WO 9309808A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- upa
- antibody
- vol
- cells
- binding
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5509252A JPH07501524A (en) | 1991-11-18 | 1992-10-27 | Method for detecting and separating uPA-R and method for inhibiting binding of uPA to uPA-R |
EP92922134A EP0642354A4 (en) | 1991-11-18 | 1992-10-27 | METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79320891A | 1991-11-18 | 1991-11-18 | |
US793,208 | 1991-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993009808A1 true WO1993009808A1 (en) | 1993-05-27 |
Family
ID=25159386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/008977 WO1993009808A1 (en) | 1991-11-18 | 1992-10-27 | METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0642354A4 (en) |
JP (1) | JPH07501524A (en) |
CA (1) | CA2123874A1 (en) |
WO (1) | WO1993009808A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994028014A2 (en) * | 1993-05-28 | 1994-12-08 | Chiron Corporation | Peptide inhibitors of urokinase receptor activity |
US6025142A (en) * | 1994-07-08 | 2000-02-15 | Boehringer Mannheim Gmbh | Hydrophobic u-PAR binding site |
EP0982036A1 (en) * | 1998-08-28 | 2000-03-01 | Wilex Biotechnology GmbH | Modulation of Beta2 -integrin-mediated cell adhesion |
EP1064005A1 (en) * | 1998-03-23 | 2001-01-03 | Shafaat A. Rabbani | Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
WO2007120693A2 (en) * | 2006-04-10 | 2007-10-25 | Astrazeneca Ab | Targeted binding agents directed to upar and uses thereof |
US8105602B2 (en) | 2006-12-08 | 2012-01-31 | Tactic Pharma, Llc | Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
-
1992
- 1992-10-27 JP JP5509252A patent/JPH07501524A/en active Pending
- 1992-10-27 WO PCT/US1992/008977 patent/WO1993009808A1/en not_active Application Discontinuation
- 1992-10-27 EP EP92922134A patent/EP0642354A4/en not_active Withdrawn
- 1992-10-27 CA CA002123874A patent/CA2123874A1/en not_active Abandoned
Non-Patent Citations (15)
Title |
---|
Blood Cells, Volume 16, No. 1, issued 1990, R.F. TODD III et al., "Human Mononuclear Phagocyte Activation Antigens", pages 167-179, especially pages 169-176. * |
Cancer and Metastasis Reviews, Volume 9, issued December 1990, J.E. TESTA et al., "The Role of Urokinase-Type Plasminogen Activator in Aggressive Tumor Cell Behavior", pages 353-367, see Abstract. * |
D. CARNEY et al., "Genes and Cancer", published 1990 by John Wiley and Sons, Ltd (N.Y.), pages 173-181, see entire document. * |
Federation of European Biochemical Societies, Volume 288, No. 1-2, issued August 1991, E. RONNE et al., "Cell-Induced Potentiation of the Plasminogen Activation System is Abolished by a Monoclonal Antibody that Recognized the NH2-Terminal Domain of the Urokinase Receptor", pages 233-236, see entire document. * |
J.A. ROTH, "Monoclonal Antibodies in Cancer", published 1986 by Futura Publishing Company Inc. (Mount Kisco, N.Y.), pages 289-321, especially pages 309-321. * |
Journal of Immunologic Methods, Volume 130, No. 1, issued 12 June 1990, U. ZACHARIAS et al., "Inhibition of Urokinase Activity and Prevention of Urokinase Receptor Binding by Monoclonal Antibodies", pages 81-90, especially Abstract. * |
Journal of Investigative Dermatology, Volume 94, issued March 1990, M. DEL ROSSO et al., "Role of Specific Membrane Receptors in Urokinase-Dependent Migration of Human Keratinocytes", pages 310-316, see entire document. * |
Proceedings of the National Academy of Sciences, Volume 86, issued July 1989, J.C. KIRCHHEIMER et al., "Functional Inhibition of Endogenously Produced Urokinase Decreases Cell Proliferation in a Human Melanoma Cell Line", pages 5424-5428, especially pages 5424-5425. * |
Science, Volume 252, issued June 1991, T.A. WALDMANN, "Monoclonal Antibodies in Diagnosis and Therapy", pages 1657-1662, see entire document. * |
See also references of EP0642354A4 * |
The Journal of Cell Biology, Volume 104, No. 4, issued April 1987, J. POLLANEN et al., "Distinct Localization of Urokinase-Type Plasminogen Activator and its Type 1 Inhibitor under Cultured Human Fibroblasts and Sarcoma Cells", pages 1085-1096, especially 1085-1086. * |
The Journal of Immunology, Volume 137, No. 2, issued 15 July 1986, D.Y. LIU et al., "A Monoclonal Antibody Specific for a Monocyte-Macrophage Membrane Component Blocks the Human Monocyte Response to Migration Inhibitory Factor", pages 448-455, see entire document. * |
The Journal of Immunology, Volume 144, No. 5, issued 01 March 1990, I.F. MIZUKAMI et al., "A Structural Characterization of the Mo3 Activation Antigen Expressed on the Plasma Membrane of Human Mononuclearphagocytes", pages 1841-1848, especially pages 1841-1842. * |
Thrombosis and Haemostasis, Volume 56, No. 2, issued 21 October 1986, M.L. NOLLI et al., "A Monoclonal Antibody that Recognizes the Receptor Binding Region of Human Urokinase Plasminogen Activator", pages 214-218, see entire document. * |
Thrombosis and Haemostasis, Volume 62, No. 3, issued 1989, A. CORTI et al., "Epitope Mapping of the Anti-Urokinase Monoclonal Antibody 5B4 by Isolated Domains of Urokinase", pages 934-939, see entire document. * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994028014A2 (en) * | 1993-05-28 | 1994-12-08 | Chiron Corporation | Peptide inhibitors of urokinase receptor activity |
WO1994028014A3 (en) * | 1993-05-28 | 1995-01-26 | Chiron Corp | Peptide inhibitors of urokinase receptor activity |
US5679782A (en) * | 1993-05-28 | 1997-10-21 | Chiron Corporation | Oligonucleotides encloding peptide inhibitors of urokinase receptor activity |
US6025142A (en) * | 1994-07-08 | 2000-02-15 | Boehringer Mannheim Gmbh | Hydrophobic u-PAR binding site |
EP1064005A1 (en) * | 1998-03-23 | 2001-01-03 | Shafaat A. Rabbani | Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
EP1064005A4 (en) * | 1998-03-23 | 2004-06-09 | Shafaat A Rabbani | Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
EP0982036A1 (en) * | 1998-08-28 | 2000-03-01 | Wilex Biotechnology GmbH | Modulation of Beta2 -integrin-mediated cell adhesion |
WO2007120693A2 (en) * | 2006-04-10 | 2007-10-25 | Astrazeneca Ab | Targeted binding agents directed to upar and uses thereof |
WO2007120693A3 (en) * | 2006-04-10 | 2008-05-29 | Amgen Fremont Inc | Targeted binding agents directed to upar and uses thereof |
JP2009533446A (en) * | 2006-04-10 | 2009-09-17 | アストラゼネカ アクチボラグ | Targeted binding agent directed against uPAR and use of said binding agent |
EP2357202A1 (en) * | 2006-04-10 | 2011-08-17 | AstraZeneca AB | Targeted binding agents directed to Upar and uses thereof |
US8105602B2 (en) | 2006-12-08 | 2012-01-31 | Tactic Pharma, Llc | Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
EP0642354A1 (en) | 1995-03-15 |
CA2123874A1 (en) | 1993-05-27 |
JPH07501524A (en) | 1995-02-16 |
EP0642354A4 (en) | 1995-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gray et al. | CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. | |
KR100496063B1 (en) | Novel protein and process for producing the same | |
EP1755660B1 (en) | Method for enhancing or inhibiting insulin-like growth factor-i | |
US20070292904A1 (en) | Ephrin and EPH receptor mediated immune modulation | |
HØYER-HANSEN et al. | Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor | |
AU5787601A (en) | Composition for inhibiting macrophage activity | |
US9868787B2 (en) | Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I | |
KR20010072825A (en) | Angiocidin: A Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor | |
EP1856155B1 (en) | Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor | |
US20010041670A1 (en) | Thrombospondin-binding region of histidine-rich glycoprotein and method of use | |
US6001965A (en) | Anticancer compounds and methods | |
EP0642354A1 (en) | METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R | |
US20080014586A1 (en) | Identification of a receptor controlling migration and metastasis of skin cancer cells | |
US20040063605A1 (en) | Composition and method for the treatment or prevention of hiv infection | |
US5800814A (en) | Method for inhibition of breast tumor growth | |
AU765126B2 (en) | Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer | |
WO1998016548A1 (en) | Thrombin receptor peptides and uses thereof | |
WO2000024869A2 (en) | Methods for modulating cell fusion | |
WO1994017411A1 (en) | Methods and agents for the diagnosis and treatment of rheumatoid arthritis | |
Itzhaky et al. | The glycosylphosphatidylinositol-anchored form and the transmembrane form of CD58 are released from the cell surface upon antibody binding | |
KR20000016598A (en) | Novel protein and process for producing the same | |
Landowski | Characterization of the 67 kDa laminin binding protein | |
JPH08511941A (en) | Human cell adhesion protein AAMP-1 and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2123874 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1992922134 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1992922134 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992922134 Country of ref document: EP |